{
    "organizations": [],
    "uuid": "87993d3daafdaf5e4a3cfeb31808f2d347df6452",
    "author": "",
    "url": "https://www.reuters.com/article/brief-arena-pharmaceuticals-reports-posi/brief-arena-pharmaceuticals-reports-positive-phase-2-results-for-oasis-trial-for-etrasimod-idUSB8N1K800T",
    "ord_in_thread": 0,
    "title": "BRIEF-Arena Pharmaceuticals Reports Positive Phase 2 Results For Oasis Trial For Etrasimod",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 19, 2018 / 8:53 PM / in 9 minutes BRIEF-Arena Pharmaceuticals Reports Positive Phase 2 Results For Oasis Trial For Etrasimod Reuters Staff 1 Min Read March 19 (Reuters) - Arena Pharmaceuticals Inc: * ARENA PHARMACEUTICALS REPORTS POSITIVE PHASE 2 RESULTS FOR THE OASIS TRIAL FOR ETRASIMOD IN PATIENTS WITH ULCERATIVE COLITIS * HIGH DOSE ETRASIMOD GROUP ACHIEVED STATISTICALLY SIGNIFICANT IMPROVEMENT IN CLINICAL REMISSION IN STUDY * TRIAL MET PRIMARY, SECONDARY ENDPOINTS WITH STATISTICAL SIGNIFICANCE FOR PATIENTS GETTING HIGH DOSE ETRASIMOD FOR 12 WKS * ETRASIMOD WAS WELL TOLERATED, HAD FEWER PATIENTS WITH SERIOUS ADVERSE EVENTS VERSUS PLACEBO IN STUDY * IMPACT ON HEART RATE, ATRIOVENTRICULAR (AV) CONDUCTION LOW IN STUDY WITH NO DISCONTINUATIONS RELATED TO BRADYCARDIA OR AV BLOCK * NO INCREASES IN LIVER FUNCTION TESTS VERSUS PLACEBO, NO REPORTS OF MACULAR EDEMA OR PULMONARY FUNCTION TEST ABNORMALITIES IN STUDY * INTENDS TO INITIATE PHASE 3 PROGRAM IN ULCERATIVE COLITIS Source text for Eikon: Further company coverage:",
    "published": "2018-03-19T22:50:00.000+02:00",
    "crawled": "2018-03-19T23:08:42.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "minute",
        "pharmaceutical",
        "report",
        "positive",
        "phase",
        "result",
        "oasis",
        "trial",
        "etrasimod",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "arena",
        "pharmaceutical",
        "inc",
        "arena",
        "pharmaceutical",
        "report",
        "positive",
        "phase",
        "result",
        "oasis",
        "trial",
        "etrasimod",
        "patient",
        "ulcerative",
        "colitis",
        "high",
        "dose",
        "etrasimod",
        "group",
        "achieved",
        "statistically",
        "significant",
        "improvement",
        "clinical",
        "remission",
        "study",
        "trial",
        "met",
        "primary",
        "secondary",
        "endpoint",
        "statistical",
        "significance",
        "patient",
        "getting",
        "high",
        "dose",
        "etrasimod",
        "wks",
        "etrasimod",
        "well",
        "tolerated",
        "fewer",
        "patient",
        "serious",
        "adverse",
        "event",
        "versus",
        "placebo",
        "study",
        "impact",
        "heart",
        "rate",
        "atrioventricular",
        "av",
        "conduction",
        "low",
        "study",
        "discontinuation",
        "related",
        "bradycardia",
        "av",
        "block",
        "increase",
        "liver",
        "function",
        "test",
        "versus",
        "placebo",
        "report",
        "macular",
        "edema",
        "pulmonary",
        "function",
        "test",
        "abnormality",
        "study",
        "intends",
        "initiate",
        "phase",
        "program",
        "ulcerative",
        "colitis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}